Aspiriant LLC’s VanEck Rare Earth/Strategic Metals ETF REMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,446
Closed -$299K 276
2022
Q2
$299K Buy
+3,446
New +$338K 0.01% 214

Other funds holding REMX

Aspiriant LLC's REMX Position: Q3 2022 in Review

Aspiriant LLC sold out of VanEck Rare Earth/Strategic Metals ETF (REMX) in Q3 2022, closing a stake of 3,446 shares — an estimated $299K sold.

Aspiriant LLC first reported a position in REMX in Q2 2022 and held it in 1 quarter. The position peaked at $299K in Q2 2022. 161 funds tracked by Wall St. Rank hold REMX as of Q3 2022.

  • Aspiriant LLC reported no remaining VanEck Rare Earth/Strategic Metals ETF position as of Q3 2022 after selling out during the quarter.
  • Aspiriant LLC sold 3,446 VanEck Rare Earth/Strategic Metals ETF shares in Q3 2022, an estimated $299K.
  • Aspiriant LLC first reported a position in VanEck Rare Earth/Strategic Metals ETF in Q2 2022 and held it in 1 quarter.
  • Aspiriant LLC's VanEck Rare Earth/Strategic Metals ETF position peaked at $299K in Q2 2022.
  • 161 funds tracked by Wall St. Rank held VanEck Rare Earth/Strategic Metals ETF as of Q3 2022.

Based on Aspiriant LLC's 13F filing for Q3 2022, filed 28 Oct 2022.